Healcisio Inc

Healcisio Inc. is a Software as a Medical Device (SaMD) company established in 2021. Headquartered in the United States, the company is a small enterprise with a team of four employees. Healcisio specializes in developing predictive analytics models for healthcare. Their flagship product, SEPSIO, runs on the COMPOSER Platform, an interoperable system designed for seamless integration with existing healthcare infrastructures. The company's primary target customers are hospitals seeking to enhance patient care through data-driven insights. Healcisio's key differentiator lies in its real-world application approach. Their predictive analytics model, SEPSIO, is currently undergoing beta testing by medical professionals in two hospitals within the UC San Diego network. This live, blind-mode testing allows Healcisio to refine their model based on actual clinical data, ensuring its accuracy and effectiveness in real-world settings. The company is also progressing towards an FDA submission for SEPSIO, demonstrating their commitment to rigorous regulatory standards. For further information or inquiries, please visit Healcisio's website at healcisio.com.